HC Wainwright & Co. Maintains Buy on WAVE Life Sciences, Raises Price Target to $15
HC Wainwright & Co. Maintains Buy on WAVE Life Sciences, Raises Price Target to $15
HC Wainwright & Co.維持對WAVE Life Sciences的買入,將目標股價提高至15美元
HC Wainwright & Co. analyst Andrew Fein maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $8 to $15.
HC Wainwright & Co. 分析師安德魯·費恩維持WAVE Life Sciences(納斯達克股票代碼:WVE)的買入並將目標股價從8美元上調至15美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。